New Orleans, LA - Results of a new randomized comparison shows that weekly home INR monitoring is safe but did not reduce stroke, major bleeds, or death when compared with monthly clinic-based INR ...

Please provide your email address to receive an email when new articles are posted on . If I were a patient on long-term warfarin, I would want an international normalized ratio home monitor. It would ...

Alere has announced a voluntary withdrawal of the Alere INRatio and INRatio 2 PT/INR Monitoring System. Alere has announced a voluntary withdrawal of the Alere INRatio and INRatio 2 PT/INR Monitoring ...

Alere has issued a voluntary correction to users of the Alere INRatio and INRatio 2 PT/INR Monitor system of certain medical conditions that should not be tested with the system (INRatio Monitor ...

At-home patient self-monitoring of warfarin therapy yielded similar results to monitoring performed in a clinic setting and randomized trials, particularly among those who self-tested on a weekly ...

Devices are available that enable patients who take warfarin to measure their INR values at home. Patients with such devices can adjust their warfarin doses as needed after phone consultations with ...

Real-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows excellent time in therapeutic range. Point-of-care, home international normalized ...

Potential problems with the point-of-care device used to monitor warfarin in ROCKET AF did not appear to have a meaningful impact on the trial results, an analysis by study investigators shows. The ...

Point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) for self-monitoring coagulation status in people on long-term vitamin K antagonist therapy who have atrial ...

Two physicians who were unaware of study-group assignments reviewed baseline medical history and adverse events identified during trial follow-up for all patients enrolled in the trial for any of the ...

WALTHAM, Mass., Dec. 8, 2014 /PRNewswire/ -- Alere Inc. has initiated a voluntary correction to inform U.S. users of the Alere INRatio(R) and INRatio(R)2 PT/INR Monitor system of certain medical ...